top of page

AI Hiring, Telehealth Prescribing, and Nonprofit Transparency: New Research from ARA

Oct 28
2 min read

Three October 2026 publications examine an AI hiring lawsuit, New Jersey’s new telehealth prescribing law, and what research shows about nonprofit disclosure.


This month, Agard Research Associates Inc. released three new publications. Each one separates what the record establishes from what remains open, whether the question concerns a federal lawsuit, a new state law, or research on nonprofit disclosure.


Reading graphic

Mobley v. Workday: What the AI Hiring Lawsuit Alleges and What the Court Has Decided

By Alyssa I. Agard


Can a software company be held responsible when its AI screens out job applicants? In Mobley v. Workday, Inc., four job seekers claim that Workday’s AI screening tools screen out a disproportionate share of applicants who are Black, female, over 40, or disabled. More than 15,000 people have opted in to their age discrimination claim. Workday denies the allegations and argues that the federal anti-discrimination laws at issue do not cover it. This brief separates the plaintiffs’ allegations from the court’s actual rulings. The court has allowed most of the disparate impact claims to proceed at the pleading stage, where a judge assumes the allegations are true, but it has not decided whether Workday’s tools caused any disparity. A hearing on class certification is listed for March 9, 2027. The brief also explains how New Jersey’s Law Against Discrimination and recent state guidance and rules apply to employers that use automated hiring tools, including tools they did not build.



Telehealth Prescribing of Schedule II Substances in New Jersey

By Shruthi Nandakumar


New Jersey’s new telehealth law, P.L.2026, c.40, changes when providers may prescribe Schedule II medications remotely. Adults may now begin a stimulant prescription through a telehealth exam, as long as they are seen in person within 30 days and at least once a year after that. The law also lifts the state’s default in-person requirement for patients in cancer treatment, hospice, palliative care, or long-term care, for patients seeking medical aid in dying, and for medications that treat substance use disorder. As introduced, the bill would have dropped the in-person requirement altogether; the enacted version is narrower. Federal law still sets the outer limit. The DEA’s temporary telemedicine flexibilities expire on December 31, 2026, and a final federal rule remains under review, so remote starts may not survive the new year. This policy analysis also finds that research on remote prescribing is thin and mostly indirect, and that the law contains no requirement to report on or evaluate its effects.



Nonprofit Transparency and Public Trust: An Annotated Bibliography for Nonprofit Leaders

Annotations by Christopher N. Gomes


Does transparency build public trust, or does it simply follow strong performance? This workshop resource reviews eight peer-reviewed studies from the United States, the United Kingdom, New Zealand, Spain, and Belgium on how nonprofits share information and how donors and other stakeholders respond. Large U.S. studies link fuller disclosure to higher donations and contributions, especially for organizations with strong financial results. None of the eight studies, however, shows that disclosure causes trust. Studies in Spain and Belgium find reporting weakest on social impact and on information that readers can verify. Each entry summarizes a study’s methods, findings, and limits, and each section closes with discussion questions that boards and staff can apply to their own organizations.

Comments


Reasearch Organization Registry (ROR) Logo

859 US Highway 130 

Ste 5 PMB 5020 

East Windsor, NJ 08520-2900

© 2026 Agard Research Associates Inc. This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. 


© 2026 Agard Research Associates Inc. All written, visual, and digital content on this site is protected by U.S. and international copyright law. Unauthorized reproduction or distribution is prohibited.​​

bottom of page